Cabaletta Bio (CABA) Other Working Capital Changes (2018 - 2025)
Cabaletta Bio (CABA) posted quarterly Other Working Capital Changes of -$1.1 million for Q4 2025, down 237.99% year-over-year from $766000.0 in Q4 2024, and little changed quarter-over-quarter from -$1.1 million in Q3 2025.
Analysis
Cabaletta Bio (CABA) Other Working Capital Changes (2018 - 2025) Analysis & Trends
Cabaletta Bio's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$1.1 million for Q4 2025.
- In Q4 2025, Other Working Capital Changes fell 237.99% year-over-year to -$1.1 million; the TTM figure through Dec 2025 stood at -$4.2 million (down 28.44% YoY), while the FY2025 annual figure was -$4.2 million, down 28.44% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$1.1 million, roughly flat from -$1.1 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $3.3 million in Q4 2021, with the low at -$1.5 million in Q2 2021.
- The 5-year median for Other Working Capital Changes is $104500.0 (2025), against an average of $172050.0.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes jumped 202.54% in 2024, then sank 237.99% in 2025.
- Cabaletta Bio's Other Working Capital Changes stood at -$2.9 million in 2022, then jumped by 74.33% to -$747000.0 in 2023, then surged by 202.54% to $766000.0 in 2024, then tumbled by 237.99% to -$1.1 million in 2025.
- Business Quant data shows CABA's Other Working Capital Changes at -$1.1 million in Q4 2025, -$1.1 million in Q3 2025, and -$1.1 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Cabaletta Bio | 522.26 Mn | 522.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.06 Mn |
| Dec 31, 2025 | -1.06 Mn |
| Sep 30, 2025 | -1.06 Mn |
| Sep 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -1.06 Mn |
| Mar 31, 2025 | -1.06 Mn |
| Dec 31, 2024 | 766,000.00 |
| Dec 31, 2024 | 766,000.00 |
| Sep 30, 2024 | -1.84 Mn |
| Sep 30, 2024 | -1.84 Mn |
| Jun 30, 2024 | -968,000.00 |
| Jun 30, 2024 | -968,000.00 |
| Mar 31, 2024 | -1.25 Mn |
| Mar 31, 2024 | -1.25 Mn |
| Dec 31, 2023 | -747,000.00 |
| Dec 31, 2023 | -747,000.00 |
| Sep 30, 2023 | -570,000.00 |
| Sep 30, 2023 | -570,000.00 |